The Soft Mist Inhaler (Respimat,SMI) Market size is expected to grow at an annual average of CAGR 2% during the forecast period (2024-2031). The Soft Mist Inhaler (SMI), such as Respimat, represents an advanced type of inhalation device used primarily for delivering medications directly into the lungs. It is known for delivering a fine, slow-moving […]
